The listed publications and posters are provided in Adobe® Acrobat Reader format. If you do not have Acrobat Reader installed on your computer, you may download it from the Acrobat® resource page.
Cancer Stem Cell Publications:
October 2007
Laurie E Ailles and Irving L Weissman
"Cancer stem cells in solid tumors"
Current Opinion in Biotechnology, Volume 18, pages 460-466
December 2007
Sanchez-Garcia, C. Vicente-Duenas, and C. Cobaleda
"The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?"
Bioessays, Volume 29, pages 1269-1280
Antibody Therapy Publications:
Monoclonal antibody therapy of cancer
G.P. Adams and L.M. Weiner (2005) Nature Biotechnology Volume 23, pages 1147-1157
Monoclonal antibody mechanisms of action in cancer.
G.J. Weiner (2007) Immunologic Research, Volume 39, pages 271-278
RAV12 Scientific Publications:
March 1, 2007
Loo et al.
"The glycotope-specific RAV12 monoclonal antibody induces oncosis in vitro and has antitumor activity against gastrointestinal adenocarcinoma tumor xenografts in vivo"
Molecular Cancer Therapeutics, Volume 6: pages 856-865
September 15, 2007
Jonathan Chi-Hang Li and Ronghao Li
"RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205"
Cancer Research, Volume 67: pages 8856-8864
Raven Scientific Presentations and Posters:
May 30 - June 3, 2008
American Society of Clinical Oncology Annual Meeting, Chicago, Illinois
RAV12 Phase 1 Experience
April 13-15, 2008
American Association for Cancer Research Annual Meeting, San Diego, California
B7-H3 Presentation
Cancer Stem Cells
KID24
RAV12
December 6, 2007
Jennie Mather, PhD, Founder, President and Chief Scientific Officer
Antibody Engineering Conference, San Diego, California
"MAbs to Cancer Stem Cell Lines Have Anti-tumor Activity"
December 5, 2007
George Schreiner, MD, PhD, Chief Executive Officer
National Institutes of Health (NIH) Workshop, Bethesda, Maryland
"Immunological Implications of Radiation Conditioning"
October 24, 2007
Kathleen King, Scientist
American Association of Cancer Research (AACR)
International Conference on Molecular Targets and Cancer Therapeutics, San Francisco, California
“Antibodies Generated by Conditioned Cell Immunization Technology Bind to Beta5 Integrin and Synergize with Chemotherapy and Radiation to Inhibit the Growth of Human Tumor Cells”
June 25, 2007
Jennie Mather, PhD, Founder, President and Chief Scientific Officer
INFORMA: 6th International Congress on Recombinant Antibodies
Novel Therapeutic Applications of Antibodies section Berlin, Germany
“Simultaneous Antibody and Target Discovery”
June 18, 2007
Jennie Mather, PhD, Founder, President and Chief Scientific Officer
24th International Conference on Advances in the Application of Monoclonal
Antibodies in Clinical Oncology Limassol, Cyprus
“RAV12: An Antibody to a Novel Glycotope Present on Adenocarcinomas”
Other Raven Presentations and Posters Available to Download: